PD-L1 reverse signaling in dermal DCs promotes DC migration and skin immunity to cutaneous pathogens

真皮 DC 中的 PD-L1 反向信号传导促进 DC 迁移和皮肤对皮肤病原体的免疫

基本信息

  • 批准号:
    10093965
  • 负责人:
  • 金额:
    $ 45.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-21 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary The goal of this proposal is to identify the mechanism(s) by which PD-L1 reverse signaling in dendritic cells (DC) initiates DC trafficking, T cell priming and T cell programming during cutaneous infection. Our studies have outlined a major role for PD-L1 reverse signaling in the control of DC migration from the skin to the draining lymph node. Intriguingly, this loss of migration appears to be dependent on TLR stimulation or infections that initiate type 1 IFN signaling. These findings are consistent with PD-L1 acting to mitigate type 1 IFN signaling events. We also outline a requirement for PD-L1 reverse signaling in chemokine, but not S1P, responsiveness demonstrating a new role for PD-L1 in regulating chemokine signaling. Finally, we find T cell priming in the lymph node is significantly decreased in the absence of PD-L1 reverse signaling. However, these defects in T cell priming only occur when DC trafficking is required, and not when antigens drain directly through the lymphatics and to the LN nor following systemic infection. Therefore, in this proposal we aim to better understand the requirements for PD-L1 reverse signaling in dendritic cell transmigration through the lymphatic capillaries. We also aim to understand how the extracellular and intracellular domains of PD-L1 may control responsiveness to chemokines. Finally, we aim to address the contribution of DC retention in the skin caused by loss of PD-L1 signaling to tissue resident memory responses established after vaccinia scarification.
项目摘要 这项建议的目标是确定PD-L1逆转树突状细胞信号的机制(S (DC)在皮肤感染期间启动DC转运、T细胞启动和T细胞编程。我们的研究 概述了PD-L1反向信号在控制DC从皮肤向皮肤迁移中的主要作用 引流淋巴结节。有趣的是,这种迁移的损失似乎依赖于TLR的刺激或 启动1型干扰素信号的感染。这些发现与PD-L1缓解1型糖尿病的作用是一致的 干扰素信号事件。我们还概述了趋化因子对PD-L1反向信号的要求,但不是S1P, 反应性显示了PD-L1在调节趋化因子信号中的新作用。最后,我们发现T细胞 在没有PD-L1反向信号的情况下,淋巴结中的启动显著减少。然而, T细胞启动中的这些缺陷只有在需要DC运输时才会发生,而不是在抗原直接排出时发生 通过淋巴管和LN,也不会在全身感染之后发生。因此,在这项提案中,我们的目标是 更好地理解树突状细胞迁移过程中PD-L1反向信号的要求 毛细淋巴管。我们还旨在了解PD-L1的胞外和胞内结构域如何 控制对趋化因子的反应。最后,我们的目标是解决DC在皮肤中滞留的贡献 由于失去PD-L1信号,导致在牛痘病毒划痕后建立的组织驻留记忆反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Beth Ann Tamburini其他文献

Beth Ann Tamburini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Beth Ann Tamburini', 18)}}的其他基金

Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    10724082
  • 财政年份:
    2022
  • 资助金额:
    $ 45.24万
  • 项目类别:
PD-L1 reverse signaling in dermal DCs promotes DC migration and skin immunity to cutaneous pathogens
真皮 DC 中的 PD-L1 反向信号传导促进 DC 迁移和皮肤对皮肤病原体的免疫
  • 批准号:
    10461928
  • 财政年份:
    2020
  • 资助金额:
    $ 45.24万
  • 项目类别:
PD-L1 reverse signaling in dermal DCs promotes DC migration and skin immunity to cutaneous pathogens
真皮 DC 中的 PD-L1 反向信号传导促进 DC 迁移和皮肤对皮肤病原体的免疫
  • 批准号:
    10676169
  • 财政年份:
    2020
  • 资助金额:
    $ 45.24万
  • 项目类别:
Molecular tracking of antigen following vaccination
疫苗接种后抗原的分子追踪
  • 批准号:
    10307136
  • 财政年份:
    2020
  • 资助金额:
    $ 45.24万
  • 项目类别:
PD-L1 reverse signaling in dermal DCs promotes DC migration and skin immunity to cutaneous pathogens
真皮 DC 中的 PD-L1 反向信号传导促进 DC 迁移和皮肤对皮肤病原体的免疫
  • 批准号:
    10267698
  • 财政年份:
    2020
  • 资助金额:
    $ 45.24万
  • 项目类别:
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    10443440
  • 财政年份:
    2016
  • 资助金额:
    $ 45.24万
  • 项目类别:
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    9225166
  • 财政年份:
    2016
  • 资助金额:
    $ 45.24万
  • 项目类别:
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    9122818
  • 财政年份:
    2016
  • 资助金额:
    $ 45.24万
  • 项目类别:
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    10614040
  • 财政年份:
    2016
  • 资助金额:
    $ 45.24万
  • 项目类别:
Cooperation between lymphatic stroma and hematopoietic cells shapes protective immunity
淋巴基质和造血细胞之间的合作形成保护性免疫
  • 批准号:
    10758027
  • 财政年份:
    2016
  • 资助金额:
    $ 45.24万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.24万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了